Sono-Tek sells first coating system to major firm:
This article was originally published in Clinica
Milton, New York-based Sono-Tek has sold its first MediSonic coating system to an undisclosed major manufacturer of stents and pharmaceuticals. The system uses an ultrasonic nozzle designed specifically for the application. The technology allows for the application of thin and precisely-controlled films on intricate 3D surfaces, such as stents. Sono-Tek claims its system avoids surface abnormalities present with other coating technologies. In addition, the company says that the coating of multiple stents with thin layers results in more economic use of expensive anti-restenosis drugs.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.